News

CLINUVEL
Posted by CLINUVEL
March 17, 2023

DNA Repair data presented at American Academy of Dermatology Meeting

First results of afamelanotide in xeroderma pigmentosum C (XPC) presented to Photodermatology...

Read More
CLINUVEL
Posted by CLINUVEL
March 13, 2023

Statement on Silicon Valley Bank (SVB)

Melbourne, Australia, 13 March 2023 ASX: CUV Börse Frankfurt: UR9 ADR Level...

Read More
Lachlan Hay
Posted by Lachlan Hay
March 10, 2023
CLINUVEL
Posted by CLINUVEL
March 10, 2023

News Communiqué I - Maestro Jaap van Zweden

Introducing CLINUVEL Intriguing Personality (CUVIP), Maestro Jaap van Zweden.

Read More
Lachlan Hay
Posted by Lachlan Hay
March 9, 2023

Commercial Update SCENESSE®

CLINUVEL today published its 2022 status report on the commercial distribution of...

Read More
CLINUVEL
Posted by CLINUVEL
March 2, 2023

Relief from Quarterly Reporting

Melbourne, Australia, 2 March 2023 ASX: CUV Börse Frankfurt: UR9 ADR Level...

Read More
CLINUVEL
Posted by CLINUVEL
March 1, 2023

CLINUVEL launches CYACÊLLE, Next Generation Solar Care

Melbourne, Australia, 01 March 2023 ASX: CUV Börse Frankfurt: UR9 ADR Level...

Read More
CLINUVEL
Posted by CLINUVEL
March 1, 2023

CYACÊLLE Polychromatic Solar Care – λ3

Melbourne, Australia, 01 March 2023 ASX: CUV Börse Frankfurt: UR9 ADR Level...

Read More
CLINUVEL
Posted by CLINUVEL
February 28, 2023

Proposed issue of Securities

Melbourne, Australia, 28 February 2023 ASX: CUV Börse Frankfurt: UR9 ADR Level...

Read More
CLINUVEL
Posted by CLINUVEL
February 24, 2023

Global SCENESSE® demand drives increased CLINUVEL revenues, earnings

Melbourne, Australia, 24 February 2023 ASX: CUV Börse Frankfurt: UR9 ADR Level...

Read More